Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

The gold miner is back from its roadshow and ready to press play on a divestment, just as record-high bullion prices spike ...

A Korean research team has successfully developed an advanced electrochemical catalyst. This innovation is expected to lead ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) have received an average recommendation of “Buy” from the nine ratings firms that are currently covering the firm, MarketBeat ...

Interim data from phase 2 KYSA-6 study, using KYV-101 for the treatment of patients with Myasthenia Gravis, expected 2nd half ...

The money is coming out of General Catalyst’s “Customer Value” fund ... equity raises — the last round was $120 million at a $1 billion valuation back in 2022 — remains untouched.

They're users of the Blackwell chips," EMJ Capital founder and Nvidia bull Eric Jackson told me on Yahoo Finance's Opening Bid podcast on the potential next Nvidia stock catalyst (video above ...

Four years into the mutually negotiated 10-year contract between Diabeter, a type 1 diabetes mellitus care-integrated ...

The serious mistake that investors are at risk of making is buying Cardano now in the expectation that the stockpile will ...

Cardano price remains in a tight range this week as crypto investors reacted to numerous events like the Fed decision and ...

Sound Stewardship LLC grew its holdings in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 2.9% in the fourth quarter, ...